0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Global Rivastigmine Market Is Estimated To Witness High Growth Owing To Increasing Geriatric Population And Rising Prevalence Of Alzheimer's DiseaseMarket Overview:Rivastigmine is a medication used to treat mild to moderate dementia caused by Alzheimer's or Parkinson's disease. It belongs to the cholinesterase inhibitors class of drugs and is available in the form of oral capsules, oral solutions, and transdermal patches. The market for Rivastigmine is driven by the increasing geriatric population worldwide and the rising prevalence of...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Rivastigmine Market Poised for Growth Due to Rising Adoption of Novel Drug Delivery SystemsRivastigmine is primarily used in the treatment of mild to moderate Alzheimer's disease and Parkinson's disease dementia symptoms. It helps in improving the symptoms of mental decline by inhibiting the breakdown of acetylcholine, a chemical messenger important for thinking, learning, and memory. The drug is administered orally through capsules or transdermal patches for continuous delivery into...0 Комментарии 0 Поделились 575 Просмотры 0 предпросмотр